Glück Conviction Score™ ⓘ
CVKD
Cadrenal Therapeutics, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 62 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv: Schwach
Sehr niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
35,0
4 neu, 2 erhöht, -414K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 5.10 | -27.5 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 8.65 | -57.2 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 4.56 | EMA50: 5.17 | |
| MACD-Histogramm | Bärisch | 10 % | -0.072 | Bearisch | |
| RSI(14) | Neutral | 10 % | 30.3 | Neutral (30–70) | |
| Stoch %K(14) | Bullisch | 5 % | 0.0 | Überverkauft | |
| ADX(14)+DI | Neutral | 10 % | 21.1 | +DI: 9.5 / −DI: 23.9 | |
| Z-Score(60) | Bullisch | 5 % | -2.06 | Extrem überverkauft | |
| 52W-Position | Bärisch | 5 % | 0.0 % | Hoch 14.99 / Tief 3.70 | |
| Bollinger(20,2σ) | Bullisch | 5 % | 0.7 % | Upper 5.56 / Mid 4.62 / Lower 3.69 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0170 | R²=0.17 / annualisiert -82.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | Pham Quang X | Director, Officer, 10% Owner, Chairman, CEO and Interim CFO | Open Market Sale | -3.500 | 4,21 | -14.735,00 | -56,2% | |
| 2026-06-09 | Pham Quang X | Director, Officer, 10% Owner, Chairman, CEO and Interim CFO | Open Market Sale | -12.992 | 4,06 | -52.747,52 | -201,0% | |
| 2026-06-08 | Pham Quang X | Director, Officer, 10% Owner, Chairman, CEO and Interim CFO | Open Market Sale | -5.893 | 4,38 | -25.811,34 | -98,4% | |
| 2026-06-05 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -2.064 | 4,42 | -9.122,88 | -34,8% | |
| 2026-06-04 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -3.898 | 4,41 | -17.190,18 | -65,5% | |
| 2026-06-03 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -2.323 | 4,26 | -9.895,98 | -37,7% | |
| 2026-06-02 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -349 | 4,46 | -1.556,54 | -5,9% | |
| 2026-05-29 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -303 | 5,01 | -1.518,03 | -5,8% | |
| 2026-05-28 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -2.989 | 4,93 | -14.735,77 | -56,2% | |
| 2026-05-22 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -1.165 | 5,69 | -6.628,85 | -25,3% | |
| 2026-05-12 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -3.298 | 5,28 | -17.413,44 | -66,4% | |
| 2026-05-11 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -6.476 | 5,76 | -37.301,76 | -142,1% | |
| 2025-12-29 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -9.933 | 6,97 | -69.233,01 | -263,8% | |
| 2025-10-27 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -1.800 | 13,99 | -25.182,00 | -96,0% | |
| 2025-10-27 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -1.315 | 13,99 | -18.396,85 | -70,1% | |
| 2025-10-24 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -1.800 | 13,99 | -25.182,00 | -96,0% | |
| 2025-10-24 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -1.129 | 14,03 | -15.839,87 | -60,4% | |
| 2025-10-13 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -1.800 | 14,15 | -25.470,00 | -97,1% | |
| 2025-10-13 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -1.800 | 14,07 | -25.326,00 | -96,5% | |
| 2025-10-09 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -1.800 | 14,02 | -25.236,00 | -96,2% | |
| 2025-10-09 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -1.693 | 13,99 | -23.685,07 | -90,3% | |
| 2025-10-06 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -107 | 13,99 | -1.496,93 | -5,7% | |
| 2025-10-02 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -500 | 14,13 | -7.065,00 | -26,9% | |
| 2025-10-01 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -1.700 | 13,99 | -23.783,00 | -90,6% | |
| 2025-10-01 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -881 | 14,01 | -12.342,81 | -47,0% | |
| 2025-09-29 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -419 | 14,01 | -5.870,19 | -22,4% | |
| 2025-09-29 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -100 | 14,00 | -1.400,00 | -5,3% | |
| 2025-09-25 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -10.900 | 14,05 | -153.182,06 | -583,7% | |
| 2025-09-25 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -6.790 | 14,09 | -95.671,10 | -364,6% | |
| 2025-09-24 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -2.581 | 13,99 | -36.108,19 | -137,6% | |
| 2025-09-24 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -1.500 | 14,00 | -20.992,95 | -80,0% | |
| 2025-08-28 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -400 | 14,00 | -5.600,00 | -21,3% | |
| 2025-08-28 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -1.193 | 13,99 | -16.690,07 | -63,6% | |
| 2025-08-27 | Pham Quang X | Director, Officer, 10% Owner, CEO and Chairman | Open Market Sale | -3.836 | 13,99 | -53.665,64 | -204,5% | |
| 2025-08-27 | Szot Matthew K | Officer, Chief Financial Officer | Open Market Sale | -1.600 | 14,00 | -22.392,00 | -85,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 53.912 | 0 | 53.912 | 365.524 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 45.201 | 0 | 45.201 | 231.429 | Neu | +100,0% | |
| DRW Securities, LLC | 25.152 | 0 | 25.152 | 170.530 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 21.626 | 14.528 | 7.098 | 110.724 | Aufgestockt | +48,9% | |
| LPL Financial LLC | 13.000 | 0 | 13.000 | 88.140 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 7.500 | 0 | 7.500 | 50.850 | Neu | +100,0% | |
| BlackRock, Inc. | 5.496 | 3.522 | 1.974 | 28.140 | Aufgestockt | +56,0% | |
| Tower Research Capital LLC (TRC) | 393 | 532 | -139 | 2.012 | Reduziert | -26,1% | |
| OSAIC HOLDINGS, INC. | 300 | 500 | -200 | 1.536 | Reduziert | -40,0% | |
| Destiny Wealth Partners, LLC | 200 | 0 | 200 | 1.024 | Neu | +100,0% | |
| Clearstead Advisors, LLC | 150 | 0 | 150 | 1.017 | Neu | +100,0% | |
| Rockefeller Capital Management L.P. | 150 | 300 | -150 | 768 | Reduziert | -50,0% | |
| HARBOUR INVESTMENTS, INC. | 100 | 100 | 0 | 512 | Unverändert | 0,0% | |
| MORGAN STANLEY | 100 | 1.080 | -980 | 512 | Reduziert | -90,7% | |
| WELLS FARGO & COMPANY/MN | 99 | 99 | 0 | 507 | Unverändert | 0,0% | |
| Archer Investment Corp | 35 | 35 | 0 | 179 | Unverändert | 0,0% | |
| IFP Advisors, Inc | 30 | 30 | 0 | 154 | Unverändert | 0,0% | |
| Farther Finance Advisors, LLC | 25 | 25 | 0 | 123 | Unverändert | 0,0% | |
| CALDWELL SUTTER CAPITAL, INC. | 5 | 5 | 0 | 26 | Unverändert | 0,0% | |
| UBS Group AG | 3 | 1.044 | -1.041 | 15 | Reduziert | -99,7% | |
| BANK OF AMERICA CORP /DE/ | 1 | 0 | 1 | 7 | Neu | +100,0% | |
| CURIO WEALTH, LLC | 1 | 1 | 0 | 5 | Unverändert | 0,0% | |
| CITIGROUP INC | 1 | 0 | 1 | 5 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 45.201 | 0 | +100,0% | 231.429 | 56,51 |
| GEODE CAPITAL MANAGEMENT, LLC | 21.626 | 14.528 | +48,9% | 110.724 | 27,04 |
| JPMORGAN CHASE & CO | 7.500 | 7.500 | 0,0% | 31.875 | 7,78 |
| BlackRock, Inc. | 5.496 | 3.522 | +56,0% | 28.140 | 6,87 |
| Tower Research Capital LLC (TRC) | 393 | 532 | -26,1% | 2.012 | 0,49 |
| OSAIC HOLDINGS, INC. | 300 | 500 | -40,0% | 1.536 | 0,38 |
| Destiny Wealth Partners, LLC | 200 | 0 | +100,0% | 1.024 | 0,25 |
| Rockefeller Capital Management L.P. | 150 | 300 | -50,0% | 768 | 0,19 |
| HARBOUR INVESTMENTS, INC. | 100 | 100 | 0,0% | 512 | 0,13 |
| MORGAN STANLEY | 100 | 1.080 | -90,7% | 512 | 0,13 |
| WELLS FARGO & COMPANY/MN | 99 | 99 | 0,0% | 507 | 0,12 |
| Archer Investment Corp | 35 | 35 | 0,0% | 179 | 0,04 |
| IFP Advisors, Inc | 30 | 30 | 0,0% | 154 | 0,04 |
| Farther Finance Advisors, LLC | 25 | 25 | 0,0% | 123 | 0,03 |
| CALDWELL SUTTER CAPITAL, INC. | 5 | 5 | 0,0% | 26 | 0,01 |
| UBS Group AG | 3 | 1.044 | -99,7% | 15 | 0,00 |
| CITIGROUP INC | 1 | 0 | +100,0% | 5 | 0,00 |
| CURIO WEALTH, LLC | 1 | 1 | 0,0% | 5 | 0,00 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 19 | 0,1 | 1 |
| 31.12.2025 | ✓ | 20 | 0,1 | 1 |
| 30.09.2025 | ✓ | 20 | 0,1 | 2 |
| 30.06.2025 | ✓ | 17 | 0,1 | 1 |
| 31.03.2025 | ✓ | 16 | 0,1 | 1 |
| 31.12.2024 | ✓ | 10 | 0,0 | 0 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| DRW Securities, LLC | 25.152 | 170.530 |
| Tower Research Capital LLC (TRC) | 532 | 3.607 |
| CURIO WEALTH, LLC | 1 | 7 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 14.528 | 1.818 | +14.3 % | 98.499 |
| UBS Group AG | 1.044 | 1.009 | +2882.9 % | 7.078 |
| MORGAN STANLEY | 1.080 | 200 | +22.7 % | 7.322 |
| BlackRock, Inc. | 3.522 | 144 | +4.3 % | 23.879 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| LPL Financial LLC | 13.000 | -1.200 | -8.5 % | 88.140 |
| VANGUARD GROUP INC | 53.912 | -327 | -0.6 % | 365.524 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 12.02.2025 | Havlickova 648 a.s. | Passiv (13G/A) | 4,39 % | 78.291 | -1,81 pp | |
| 12.02.2025 | Dubnica Property s.r.o. | Passiv (13G/A) | 4,39 % | 78.291 | -1,81 pp | |
| 12.02.2025 | Miroslav Dornak | Passiv (13G/A) | 4,39 % | 78.291 | -1,81 pp | |
| 29.01.2025 | The PVBQ Living Trust | Aktivist (13D) | 11,20 % | 200.000 | -11,84 pp | The shares of Common Stock reported herein as beneficially owned by the Reporting Person… |
| 29.01.2025 | Quang X. Pham | Aktivist (13D) | 23,60 % | 421.042 | -24,97 pp | The shares of Common Stock reported herein as beneficially owned by the Reporting Person… |
| 15.01.2025 | John Raymond Murphy | Passiv (13G/A) | 2,96 % | 53.205 | -2,15 pp | |
| 14.11.2024 | Steven Boyd | Passiv (13G/A) | 4,99 % | 78.611 | -5,00 pp | |
| 14.11.2024 | Armistice Capital, LLC | Passiv (13G/A) | 4,99 % | 78.611 | -5,00 pp | |
| 04.10.2024 | Miroslav Dornak | Passiv (13G) | 6,20 % | 66.332 | Neu | |
| 04.10.2024 | Havlickova 648 a.s. | Passiv (13G) | 6,20 % | 66.332 | Neu | |
| 04.10.2024 | Dubnica Property s.r.o. | Passiv (13G) | 6,20 % | 66.332 | Neu | |
| 14.02.2024 | Steven Boyd | Passiv (13G) | 9,99 % | 1.399.384 | Neu | |
| 14.02.2024 | Armistice Capital, LLC | Passiv (13G) | 9,99 % | 1.399.384 | Neu | |
| 13.02.2024 | John | Passiv (13G/A) | 5,49 % | 714.795 | Neu | |
| 12.02.2024 | Quang X. Pham | Passiv (13G) | 48,57 % | 6.325.000 | Neu | |
| 12.02.2024 | The PVBQ Living Trust | Passiv (13G) | 23,04 % | 3.000.000 | Neu | |
| 27.03.2023 | John Raymond Murphy | Passiv (13G) | 5,11 % | 594.792 | Neu |
Stammdaten
Cadrenal Therapeutics, Inc. ist ein klinisch entwickelndes biopharmazeutisches Unternehmen. Das Unternehmen konzentriert sich auf die Entwicklung von Tecarfarin, einer neuartigen Therapie mit Orphan-Drug-Indikation zur Prävention von systemischer Thromboembolie kardialen Ursprungs bei Patienten mit Niereninsuffizienz im Endstadium und Vorhofflimmern. Das Unternehmen wurde 2022 gegründet und hat seinen Sitz in Ponte Vedra, Florida.
Unternehmen & Branche
| Name | Cadrenal Therapeutics, Inc. |
|---|---|
| Ticker | CVKD |
| CIK | 0001937993 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 127636207 |
|---|---|
| ISIN | US1276362076 |
| Typ | Common Stock |
| Marktkapitalisierung | 9,4 Mio. USD |
| Beta | 1,73 |
| Dividendenrendite | 4,09 % |
Bewertung
| KBV (P/B) | 3,44 vs. 1,25 (2023) ▲ |
|---|---|
| FCF-Rendite | -133,8 % vs. -36,7 % (2023) ▼ |
Qualität & Bilanz
| ROIC | -483,3 % vs. -108,6 % (2023) ▼ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2023. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|
| Bewertung | ||||
| KBV (P/B) | 1,25 | 3,47 | 5,79 | |
| FCF-Rendite | -36,7 % | -28,5 % | -79,5 % | |
| Qualität & Bilanz | ||||
| ROIC | -108,6 % | -143,2 % | -483,3 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -2.496.540 | -1,04 | 2.862.067 | 1.797.115 | |
| 2025-12-31 | 10-K | -13.237.362 | -6,64 | 4.326.708 | 2.738.726 | |
| 2025-09-30 | 10-Q | -2.685.705 | -1,31 | 4.087.622 | 2.734.947 | |
| 2025-06-30 | 10-Q | -3.667.287 | -1,87 | 5.978.431 | 4.298.913 | |
| 2025-03-31 | 10-Q | -3.845.380 | -2,09 | 7.953.262 | 6.113.096 | |
| 2024-12-31 | 10-K | -10.651.368 | -8,73 | 10.123.533 | 7.439.575 | |
| 2024-09-30 | 10-Q | -2.407.829 | -2,18 | 4.679.293 | 3.412.351 | |
| 2024-06-30 | 10-Q | -2.392.982 | -0,15 | 5.457.171 | 3.992.254 | |
| 2024-03-31 | 10-Q | -1.663.288 | -0,10 | 7.048.431 | 6.192.116 | |
| 2023-12-31 | 10-K | -8.357.086 | -9,29 | 8.519.250 | 7.692.375 | |
| 2023-09-30 | 10-Q | -1.036.451 | -1,01 | 9.311.618 | 8.745.820 | |
| 2023-06-30 | 10-Q | -1.003.001 | -0,09 | 3.559.026 | 3.175.922 | |
| 2023-03-31 | 10-Q | -5.173.574 | -0,48 | 4.482.064 | 4.065.262 | |
| 2022-12-31 | 10-K | -6.714.329 | -0,85 | 778.174 | -5.551.150 | |
| 2022-09-30 | 10-Q | -1.026.114 | -0,13 | -1.179.823 | ||
| 2022-06-30 | 10-Q | -502.141 | 0,07 | -670.838 | ||
| 2022-03-31 | 10-Q | -176.648 | -0,02 | -169.147 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | – | -1,04 |
| Q3 2025 | 30.09.2025 | 10.11.2025 | – | -1,31 |
| Q2 2025 | 30.06.2025 | 11.08.2025 | – | -1,87 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | – | -2,09 |
| Q3 2024 | 30.09.2024 | 10.11.2025 | – | -2,18 |
| Q2 2024 | 30.06.2024 | 11.08.2025 | – | -2,24 |
| Q1 2024 | 31.03.2024 | 08.05.2025 | – | -1,56 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | – | -1,01 |
| Q2 2023 | 30.06.2023 | 07.08.2024 | – | -0,09 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 31.03.2026 | 10-K | 31.12.2025 | 90 Tage | SEC » |
| 10.11.2025 | 10-Q | 30.09.2025 | 41 Tage | SEC » |
| 11.08.2025 | 10-Q | 30.06.2025 | 42 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 13.03.2025 | 10-K | 31.12.2024 | 72 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 11.03.2024 | 10-K | 31.12.2023 | 71 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 10.08.2023 | 10-Q | 30.06.2023 | 41 Tage | SEC » |
| 10.05.2023 | 10-Q | 31.03.2023 | 40 Tage | SEC » |
| 30.03.2023 | 10-K | 31.12.2022 | 89 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (03.06.2026)
HOCH Abgang Schlüsselpersonen (03.06.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 03.06.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 01.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 18.07.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 31.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 25.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-04-30 | 1.394 | 5,59 | 7.792 |
| 2026-04-27 | 1.111 | 5,50 | 6.111 |
| 2026-04-24 | 2.596 | 5,53 | 14.356 |
| 2026-04-20 | 7.633 | 5,22 | 39.844 |
| 2026-04-13 | 4.370 | 4,76 | 20.801 |
| 2026-04-07 | 786 | 4,65 | 3.655 |
| 2026-03-23 | 406 | 6,52 | 2.647 |
| 2026-03-19 | 2.970 | 7,24 | 21.503 |
| 2026-03-18 | 3.726 | 7,54 | 28.094 |
| 2026-03-12 | 1.524 | 7,80 | 11.887 |
| 2026-03-11 | 9 | 8,00 | 72 |
| 2026-03-09 | 1.521 | 8,28 | 12.594 |
| 2026-03-06 | 1.552 | 8,00 | 12.416 |
| 2026-03-05 | 1.469 | 8,30 | 12.193 |
| 2026-03-04 | 3.864 | 8,13 | 31.414 |
| 2026-03-03 | 1.897 | 8,59 | 16.295 |
| 2026-02-27 | 3.376 | 8,38 | 28.291 |
| 2026-02-26 | 5.251 | 8,63 | 45.316 |
| 2026-02-25 | 15 | 7,79 | 117 |
| 2026-02-24 | 1.098 | 6,71 | 7.368 |
| 2026-02-23 | 2.882 | 6,85 | 19.742 |
| 2026-02-20 | 342 | 6,21 | 2.124 |
| 2026-02-18 | 15 | 4,91 | 74 |
| 2026-02-13 | 1.377 | 5,42 | 7.463 |
| 2026-01-29 | 6.300 | 7,66 | 48.258 |
| 2026-01-28 | 2.058 | 7,62 | 15.682 |
| 2026-01-27 | 6.391 | 7,70 | 49.211 |
| 2026-01-20 | 3.222 | 7,87 | 25.357 |
| 2026-01-16 | 157 | 8,20 | 1.287 |
| 2026-01-15 | 2.704 | 8,40 | 22.714 |
| 2026-01-13 | 1.771 | 8,53 | 15.107 |
| 2026-01-06 | 4.000 | 7,32 | 29.280 |
| 2026-01-05 | 5.329 | 7,33 | 39.062 |
| 2025-12-30 | 288 | 6,91 | 1.990 |
| 2025-12-24 | 14.758 | 7,24 | 106.848 |
| 2025-12-19 | 2 | 7,37 | 15 |
| 2025-12-17 | 4.662 | 8,25 | 38.462 |
| 2025-12-15 | 450 | 11,00 | 4.950 |